Evaluación de los resultados estéticos tras liposucción asistida por láser para ginecomastia

Traditional surgical treatment for gynecomastia has multiple complications. Recently, energy-based therapies have gained popularity over conventional surgical treatments, including liposuction using radiofrequency energy, power-assisted liposuction, ultrasound-assisted liposuction, and laser-assisted lipolysis (LAL). This work aims to assess LAL efficacy and glandular tissue treatment using a 1470-nm laser for gynecomastia to correct breast volume, flaccidity, and skin tightening without its removal.

This prospective, single-blinded randomized controlled trial was conducted on 30 patients enrolled in the National Institute of Laser Enhanced Sciences outpatient clinic who had gynecomastia classified according to the Simon standard. The participants were randomly allocated to 2 groups: group 1 (n = 15) received conventional liposuction (suction-assisted liposuction), and group 2 received LAL (1470-nm diode laser) treatment. Patients were assessed using the BREAST-Q scale.

All patients achieved satisfactory results. The BREAST-Q scores were significantly higher in group 2 compared with group I (P < 0.005). Visual analog scale scores significantly decreased in group 2 (P < 0.001) compared with group 1. Group 2 had significantly improved aesthetic outcomes compared with group 1 (P < 0.001). In group 1, skin retraction and hematoma incidence were significantly greater than in group 2 (P = 0.014, <0.001).

The LAL described is safe and reproducible. It showed a higher BREAST-Q value, a significantly better aesthetic outcome, and fewer postoperative complications.